Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.160
+0.030 (1.41%)
Dec 20, 2024, 4:00 PM EST - Market closed
Minerva Neurosciences Employees
Minerva Neurosciences had 9 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$367,950
Market Cap
15.11M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ProPhase Labs | 113 |
bioAffinity Technologies | 75 |
BioXcel Therapeutics | 74 |
GlycoMimetics | 35 |
Nephros | 31 |
Unity Biotechnology | 19 |
Traws Pharma | 18 |
Acurx Pharmaceuticals | 4 |
NERV News
- 6 weeks ago - Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 8 months ago - Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 10 months ago - US FDA declines to approve Minerva Neurosciences' schizophrenia drug - Reuters
- 10 months ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences: There's Probably Time For One More Rally - Seeking Alpha
- 1 year ago - Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market - GlobeNewsWire